Viewing Study NCT07053020


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT07053020
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-08
First Post: 2025-06-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module